SELLAS Life Sciences Group, Inc. SLS
NasdaqMid CapHealthcare
13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $9.3M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Top Institutional Holders
as of Q2 2026$222.44M+23.5%
$191.83M+54.8%
$121.42M+9.3%
$72.11M+24.8%
$66.42MNew
$31.90M+47.7%
$30.27M+416.5%
$28.55M+37.6%
$23.91M+27.0%
$19.71M+11.0%
$18.49M+68.1%
$18.25M-7.5%
$18.19M+19.8%
$15.82M+2180.1%
$11.63M+22.8%
$8.82M+73.2%
$8.64M+5.2%
$8.34M+17.6%
$7.82M+10.8%
$7.50MNew
$6.18M-37.6%
$5.69M+11.3%
$5.54M-46.2%
$5.32MNew
$5.30MNew
Reading the latest SEC filing…